Simotinib hydrochloride structure
|
Common Name | Simotinib hydrochloride | ||
---|---|---|---|---|
CAS Number | 1538617-88-7 | Molecular Weight | 537.41 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H27Cl2FN4O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Simotinib hydrochlorideSimotinib hydrochloride is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 19.9 nM. Antineoplastic activities[1]. |
Name | Simotinib hydrochloride |
---|
Description | Simotinib hydrochloride is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 19.9 nM. Antineoplastic activities[1]. |
---|---|
Related Catalog | |
Target |
EGFR:19.9 nM (pIC50) |
In Vitro | Simotinib hydrochloride inhibits in a dose-dependent manner EGFR and the growth of human A431 tumor cells with high expression of EGFR, with no significant activity on other investigated kinases[1]. |
In Vivo | Simotinib hydrochloride has been shown to exert its antitumor activity by inhibiting EGFR phosphorylation in nude xenograft model[1]. |
References |
Molecular Formula | C25H27Cl2FN4O4 |
---|---|
Molecular Weight | 537.41 |